person · Reporting owner

Wilderotter Mary Agnes

Disclosed activity across 11 companies

Tapewire entity: 2258
SEC CIK: 0001180610

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CADENCE DESIGN SYSTEMS INCCDNS · Entity 2935	Director	February 14, 2020	February 20, 2020
COSTCO WHOLESALE CORP /NEWCOST · Entity 2803	Director	October 22, 2025	October 24, 2025
DOCUSIGN, INC.DOCU · Entity 2242	Director	October 01, 2026	October 02, 2026
DXC Technology CoDXC · Entity 4594	Director	March 15, 2017	March 17, 2017
Lyft, Inc.LYFT · Entity 2493	Director	August 28, 2023	August 31, 2023
Okta, Inc.OKTA · Entity 3154	Director	August 13, 2025	August 15, 2025
Sana Biotechnology, Inc.SANA · Entity 4870	Director	June 05, 2025	June 09, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CADENCE DESIGN SYSTEMS INC

Report date February 14, 2020 · Filed February 20, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	13,235	Reported balance After 2020-02-14 transaction · row 1 1 source row Row 1 · 2020-02-14 · Grant · Acquired 2,412 · Balance 13,235 F1: Incentive stock award fully vests on February 14, 2021.

Filing footnotes · ownership attribution and instrument terms

F1: Incentive stock award fully vests on February 14, 2021.

COSTCO WHOLESALE CORP /NEW

Report date October 22, 2025 · Filed October 24, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	3,204.936	Reported balance After 2025-10-22 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2025-10-22 · Grant · Acquired 286 · Balance 3,204.936 F1: Grant of Restricted Stock Units. Vests one-third on October 22, 2026, and one-third annually on October 22 for the following two years. F2: Not applicable. Grant of Restricted Stock Units. F3: On July 21, 2025, the reporting person contributed 9,752 shares of Costco common stock to a grantor retained annuity trust (GRAT-1) of which the reporting person is the sole grantor, trustee and annuity beneficiary.
Common StockSEC Table I · non-derivative	IndirectBy GRAT-1	9,752	Reported balance Holding disclosure · report date 2025-10-22 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 9,752 F3: On July 21, 2025, the reporting person contributed 9,752 shares of Costco common stock to a grantor retained annuity trust (GRAT-1) of which the reporting person is the sole grantor, trustee and annuity beneficiary.

Filing footnotes · ownership attribution and instrument terms

F1: Grant of Restricted Stock Units. Vests one-third on October 22, 2026, and one-third annually on October 22 for the following two years.

F2: Not applicable. Grant of Restricted Stock Units.

F3: On July 21, 2025, the reporting person contributed 9,752 shares of Costco common stock to a grantor retained annuity trust (GRAT-1) of which the reporting person is the sole grantor, trustee and annuity beneficiary.

DOCUSIGN, INC.

Report date October 01, 2026 · Filed October 02, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	2,199	Reported balance After 2026-10-01 transaction · row 1 1 source row Row 1 · 2026-10-01 · Sale · Disposed 1,000 · Balance 2,199 F1: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

DXC Technology Co

Report date March 15, 2017 · Filed March 17, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance Holding disclosure · report date 2017-03-15 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 0

Lyft, Inc.

Report date August 28, 2023 · Filed August 31, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	55,493	Reported balance After 2023-08-28 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2023-08-28 · Sale · Disposed 2,403 · Balance 55,493 F1: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). F2: This transaction was executed in multiple trades at prices ranging from $10.22 to $10.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

F2: This transaction was executed in multiple trades at prices ranging from $10.22 to $10.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.

Okta, Inc.

Report date August 13, 2025 · Filed August 15, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	5,826	Reported balance After 2025-08-13 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2025-08-13 · Grant · Acquired 5,826 · Balance 5,826 F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Class A Common Stock. F2: 33-1/3% of the shares underlying the RSU shall vest on August 13, 2026, and the remaining shares underlying the RSU shall vest in 2 equal annual installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such date.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Class A Common Stock.

F2: 33-1/3% of the shares underlying the RSU shall vest on August 13, 2026, and the remaining shares underlying the RSU shall vest in 2 equal annual installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such date.

Sana Biotechnology, Inc.

Report date June 05, 2025 · Filed June 09, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.55 · Expires 2035-06-04	Direct	80,000	Reported balance After 2025-06-05 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2025-06-05 · Grant · Acquired 80,000 · Balance 80,000 F1: The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.

Filing footnotes · ownership attribution and instrument terms

F1: The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.

Past disclosures · reporting ended (4)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Fortinet, Inc.

Report date June 12, 2025 · Filed June 13, 2025

Section 16 reporting ended · disclosed 2025-06-13. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	5,069	Reported balance After 2025-06-12 transaction · row 1 1 source row Row 1 · 2025-06-12 · Exercise / conversion · Acquired 1,130 · Balance 5,069 F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2025-06-12 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2025-06-12 · Exercise / conversion · Disposed 1,130 · Balance 0 F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2024. F3: The RSUs will vest in substantially equal increments on each of September 30, 2024, December 31, 2024, March 31, 2025, and the earlier of (i) June 30, 2025 and (ii) the date immediately preceding the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F4: RSUs do not expire; they either vest or are canceled prior to vest date.

Filing footnotes · ownership attribution and instrument terms

F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2024.

F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

F3: The RSUs will vest in substantially equal increments on each of September 30, 2024, December 31, 2024, March 31, 2025, and the earlier of (i) June 30, 2025 and (ii) the date immediately preceding the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting.

F4: RSUs do not expire; they either vest or are canceled prior to vest date.

Hewlett Packard Enterprise Co

Report date April 05, 2022 · Filed April 07, 2022

Section 16 reporting ended · disclosed 2022-04-07. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	95,627	Reported balance After 2022-04-05 transaction · row 1 1 source row Row 1 · 2022-04-05 · Exercise / conversion · Acquired 14,479 · Balance 95,627
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-04-05 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-04-05 · Exercise / conversion · Disposed 14,479 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2: As previously reported, on 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 117.5568 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 07/07/21, 115.3990 dividend equivalent rights at $14.71 per RSU credited to the reporting person's account on 10/06/21, 99.0963 dividend equivalent rights at $17.13 per RSU credited to the reporting person's account on 01/07/22. F3: The number of shares in column 5 includes 333 vested RSU dividend equivalent rights and a de minimus adjustment of 0.9479 due to fractional rounding of the dividend equivalent rights at $16.26 per RSU credited to the reporting person's account on 04/05/22.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2: As previously reported, on 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 117.5568 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 07/07/21, 115.3990 dividend equivalent rights at $14.71 per RSU credited to the reporting person's account on 10/06/21, 99.0963 dividend equivalent rights at $17.13 per RSU credited to the reporting person's account on 01/07/22.

F3: The number of shares in column 5 includes 333 vested RSU dividend equivalent rights and a de minimus adjustment of 0.9479 due to fractional rounding of the dividend equivalent rights at $16.26 per RSU credited to the reporting person's account on 04/05/22.

Juno Therapeutics, Inc.

Report date March 05, 2018 · Filed March 07, 2018

Section 16 reporting ended · disclosed 2018-03-07. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.72 · Expires 2024-11-03	Direct	Reported balance After 2018-03-05 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2018-03-05 · Disposition to issuer · Disposed 75,000 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F2: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.
Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.00 · Expires 2025-06-11	Direct	Reported balance After 2018-03-05 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-03-05 · Disposition to issuer · Disposed 12,000 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F2: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.
Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.40 · Expires 2026-06-16	Direct	Reported balance After 2018-03-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-03-05 · Disposition to issuer · Disposed 12,000 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F2: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.
Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.29 · Expires 2027-06-15	Direct	Reported balance After 2018-03-05 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-03-05 · Disposition to issuer · Disposed 12,000 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F2: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

Filing footnotes · ownership attribution and instrument terms

F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent.

F2: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

PROCTER & GAMBLE Co

Report date October 15, 2015 · Filed October 15, 2015

Section 16 reporting ended · disclosed 2015-10-15. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	15,624.122	Reported balance Holding disclosure · report date 2015-10-15 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 15,624.122 F1: Total includes grant of dividend equivalents in the form of RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Total includes grant of dividend equivalents in the form of RSUs.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
January 05, 2024 Filed Jan 8, 2024 22:38 UTC	Sana Biotechnology, Inc. SANA · Entity 4870	GrantCommon Stock	1,470	$0.00	$0.00	Disclosure SEC source: 0001562180-24-000341 · primarydocument.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,106 F1 · shares: Consists of fully vested restricted stock units. Read SEC document
November 30, 2023 Filed Nov 30, 2023 23:36 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionRestricted Stock Units · Derivative	997	$0.00	$0.00	Disclosure SEC source: 0001261333-23-000093 · wk-form4_1701387403.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,995 Underlying: Common Stock · 997 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs have a vest commencement date of May 31, 2023 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
November 30, 2023 Filed Nov 30, 2023 23:36 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionCommon Stock	997	$0.00	$0.00	Disclosure SEC source: 0001261333-23-000093 · wk-form4_1701387403.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 22, 2023 Filed Oct 24, 2023 18:52 UTC	COSTCO WHOLESALE CORP /NEW COST · Entity 2803	GrantCommon Stock	489	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-23-053447 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,349 F1 · shares: Grant of Restricted Stock Units. Vests one-third on October 22, 2024, and one-third annually on October 22 for the following two years. F2 · price: Not applicable. Grant of Restricted Stock Units. Read SEC document
October 05, 2023 Filed Oct 6, 2023 20:20 UTC	Sana Biotechnology, Inc. SANA · Entity 4870	GrantCommon Stock	2,077	$0.00	$0.00	Disclosure SEC source: 0001562180-23-007237 · primarydocument.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,636 F1 · shares: Consists of fully vested restricted stock units. Read SEC document
August 31, 2023 Filed Aug 31, 2023 22:07 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionRestricted Stock Units · Derivative	997	$0.00	$0.00	Disclosure SEC source: 0001628280-23-031193 · wk-form4_1693519604.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,992 Underlying: Common Stock · 997 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs have a vest commencement date of May 31, 2023 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
August 31, 2023 Filed Aug 31, 2023 22:07 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionCommon Stock	997	$0.00	$0.00	Disclosure SEC source: 0001628280-23-031193 · wk-form4_1693519604.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 28, 2023 Filed Aug 31, 2023 00:05 UTC	Lyft, Inc. LYFT · Entity 2493	SaleClass A Common Stock	2,403	$10.29	$24,719.90	Disclosure SEC source: 0001209191-23-047789 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,493 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). F2 · price: This transaction was executed in multiple trades at prices ranging from $10.22 to $10.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document
July 05, 2023 Filed Jul 6, 2023 20:21 UTC	Sana Biotechnology, Inc. SANA · Entity 4870	GrantCommon Stock	1,245	$0.00	$0.00	Disclosure SEC source: 0001562180-23-005766 · primarydocument.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,559 F1 · shares: Consists of fully vested restricted stock units. Read SEC document
June 15, 2023 Filed Jun 16, 2023 23:31 UTC	Lyft, Inc. LYFT · Entity 2493	GrantClass A Common Stock	24,645	$0.00	$0.00	Disclosure SEC source: 0001209191-23-038113 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,896 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs shall vest on each of August 20, 2023, November 20, 2023, February 20, 2024, and the earlier of May 20, 2024 or the day prior to the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. F2 · balance_after: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU. Read SEC document
June 08, 2023 Filed Jun 9, 2023 20:33 UTC	Sana Biotechnology, Inc. SANA · Entity 4870	GrantStock Option (Right to Buy) · Derivative	65,000	$0.00 Strike: $6.70	$0.00	Disclosure SEC source: 0001562180-23-005028 · primarydocument.xml · derivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2033-06-07 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 8, 2024 and (ii) immediately prior to Sana Biotechnology, Inc.'s next annual meeting of stockholders following June 8, 2023. Read SEC document
May 31, 2023 Filed Jun 2, 2023 00:27 UTC	DOCUSIGN, INC. DOCU · Entity 2242	GrantRestricted Stock Units · Derivative	3,989	$0.00	$0.00	Disclosure SEC source: 0001628280-23-020592 · wk-form4_1685665668.xml · derivative · entry 4 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,989 Underlying: Common Stock · 3,989 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The RSUs have a vest commencement date of May 31, 2023 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
May 31, 2023 Filed Jun 2, 2023 00:27 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionRestricted Stock Units · Derivative	672	$0.00	$0.00	Disclosure SEC source: 0001628280-23-020592 · wk-form4_1685665668.xml · derivative · entry 3 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 672 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs have a vest commencement date of June 3, 2022 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
May 31, 2023 Filed Jun 2, 2023 00:27 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Tax withholdingCommon Stock	62	$0.00	$0.00	Disclosure SEC source: 0001628280-23-020592 · wk-form4_1685665668.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,354 Read SEC document
May 31, 2023 Filed Jun 2, 2023 00:27 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionCommon Stock	672	$0.00	$0.00	Disclosure SEC source: 0001628280-23-020592 · wk-form4_1685665668.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 26, 2023 Filed Jun 1, 2023 00:56 UTC	Lyft, Inc. LYFT · Entity 2493	SaleClass A Common Stock	1,827	$8.27	$15,106.37	Disclosure SEC source: 0001209191-23-033196 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,251 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). F2 · price: This transaction was executed in multiple trades at prices ranging from $8.14 to $8.435. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document
April 05, 2023 Filed Apr 6, 2023 20:46 UTC	Sana Biotechnology, Inc. SANA · Entity 4870	GrantCommon Stock	2,314	$0.00	$0.00	Disclosure SEC source: 0001562180-23-003475 · primarydocument.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,314 F1 · shares: Consists of fully vested restricted stock units. Read SEC document
March 03, 2023 Filed Mar 7, 2023 00:20 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionRestricted Stock Units · Derivative	671	$0.00	$0.00	Disclosure SEC source: 0001261333-23-000025 · wf-form4_167814844230104.xml · derivative · entry 3 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 672 Underlying: Common Stock · 671 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs have a vest commencement date of June 3, 2022 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. F4 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
March 03, 2023 Filed Mar 7, 2023 00:20 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Tax withholdingCommon Stock	81	$0.00	$0.00	Disclosure SEC source: 0001261333-23-000025 · wf-form4_167814844230104.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,744 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting and settlement of restricted stock units ("RSU"). Read SEC document
March 03, 2023 Filed Mar 7, 2023 00:20 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionCommon Stock	671	$0.00	$0.00	Disclosure SEC source: 0001261333-23-000025 · wf-form4_167814844230104.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 27, 2023 Filed Mar 2, 2023 02:05 UTC	Lyft, Inc. LYFT · Entity 2493	SaleClass A Common Stock	1,826	$10.16	$18,544.13	Disclosure SEC source: 0001209191-23-014415 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,078 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $9.96 to $10.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document
February 01, 2023 Filed Feb 3, 2023 23:01 UTC	Lyft, Inc. LYFT · Entity 2493	SaleClass A Common Stock	1,826	$16.65	$30,403.45	Disclosure SEC source: 0001209191-23-007147 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,904 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.65 to $16.655. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:18 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionRestricted Stock Units · Derivative	30,111	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000207 · wf-form4_167122548893249.xml · derivative · entry 3 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,111 Underlying: Common Stock · 30,111 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSU award will vest as follows: (i) 50% of the RSU award shall vest on the earlier of the six-month anniversary of the grant date, the appointment of a permanent chief executive officer or a change in control of the Company; and (ii) 50% of the RSU award shall vest in three equal installments, with 1/3 of the shares vesting on each of the four-month, seven-month and twelve-month anniversaries of the grant date, in each case subject to the Reporting Person's continued employment as interim Chief Executive Officer through each such date. F4 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:18 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Tax withholdingCommon Stock	10,300	$59.55	$613,365.00	Disclosure SEC source: 0001261333-22-000207 · wf-form4_167122548893249.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,154 F1 · kind: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting and settlement of restricted stock units ("RSU"). Read SEC document
December 15, 2022 Filed Dec 16, 2022 21:18 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionCommon Stock	30,111	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000207 · wf-form4_167122548893249.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 03, 2022 Filed Dec 6, 2022 00:31 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionRestricted Stock Units · Derivative	671	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000191 · wf-form4_167028664825033.xml · derivative · entry 3 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,343 Underlying: Common Stock · 671 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs have a vest commencement date of June 3, 2022 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. F4 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
December 03, 2022 Filed Dec 6, 2022 00:31 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Tax withholdingCommon Stock	100	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000191 · wf-form4_167028664825033.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,343 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting and settlement of restricted stock units ("RSU"). Read SEC document
December 03, 2022 Filed Dec 6, 2022 00:31 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionCommon Stock	671	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000191 · wf-form4_167028664825033.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 28, 2022 Filed Nov 30, 2022 21:24 UTC	Lyft, Inc. LYFT · Entity 2493	SaleClass A Common Stock	1,826	$10.87	$19,853.55	Disclosure SEC source: 0001209191-22-059042 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,730 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $10.70 to $11.04. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document
October 22, 2022 Filed Oct 25, 2022 20:49 UTC	COSTCO WHOLESALE CORP /NEW COST · Entity 2803	GrantCommon Stock	565	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-22-054532 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,860 F1 · shares: Grant of Restricted Stock Units. Vests one-third on October 22, 2023, and one-third annually on October 22 for the following two years. F2 · price: Not applicable. Grant of Restricted Stock Units. Read SEC document
September 03, 2022 Filed Sep 7, 2022 21:49 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionRestricted Stock Units · Derivative	671	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000151 · wf-form4_166258735805204.xml · derivative · entry 3 Wilderotter Mary Agnes · CIK 0001180610 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,014 Underlying: Common Stock · 671 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs have a vest commencement date of June 3, 2022 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. F4 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
September 03, 2022 Filed Sep 7, 2022 21:49 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Tax withholdingCommon Stock	134	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000151 · wf-form4_166258735805204.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,772 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting and settlement of restricted stock units ("RSU"). Read SEC document
September 03, 2022 Filed Sep 7, 2022 21:49 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionCommon Stock	671	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000151 · wf-form4_166258735805204.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 23, 2022 Filed Jun 24, 2022 21:11 UTC	DOCUSIGN, INC. DOCU · Entity 2242	GrantRestricted Stock Units · Derivative	60,222	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000121 · wf-form4_165610510583812.xml · derivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,222 Underlying: Common Stock · 60,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSU award will vest as follows: (i) 50% of the RSU award shall vest on the earlier of the six-month anniversary of the grant date, the appointment of a permanent chief executive officer or a change in control of the Company; and (ii) 50% of the RSU award shall vest in three equal installments, with 1/3 of the shares vesting on each of the four-month, seven-month and twelve-month anniversaries of the grant date, in each case subject to the Reporting Person's continued employment as interim Chief Executive Officer through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
June 16, 2022 Filed Jun 22, 2022 01:14 UTC	Lyft, Inc. LYFT · Entity 2493	GrantClass A Common Stock	18,732	$0.00	$0.00	Disclosure SEC source: 0001209191-22-038618 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,556 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs shall vest on each of August 20, 2022, November 20, 2022, February 20, 2023, and the earlier of May 20, 2023 or the day prior to the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. F2 · balance_after: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU. Read SEC document
June 07, 2022 Filed Jun 8, 2022 18:14 UTC	COSTCO WHOLESALE CORP /NEW COST · Entity 2803	PurchaseCommon Stock	850	$470.74	$400,124.75	Disclosure SEC source: 0001209191-22-034973 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,295 Read SEC document
June 06, 2022 Filed Jun 8, 2022 22:36 UTC	Sana Biotechnology, Inc. SANA · Entity 4870	GrantStock Option (Right to Buy) · Derivative	65,000	$0.00 Strike: $4.95	$0.00	Disclosure SEC source: 0001562180-22-004943 · primarydocument.xml · derivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2032-06-05 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2023 and (ii) immediately prior to Sana Biotechnology, Inc.'s next annual meeting of stockholders following June 6, 2022. Read SEC document
June 03, 2022 Filed Jun 7, 2022 01:30 UTC	DOCUSIGN, INC. DOCU · Entity 2242	GrantRestricted Stock Units · Derivative	2,685	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000098 · wf-form4_165456538689877.xml · derivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,685 Underlying: Common Stock · 2,685 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs have a vest commencement date of June 3, 2022 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
May 28, 2022 Filed Jun 1, 2022 21:50 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionRestricted Stock Units · Derivative	279	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000085 · wf-form4_165412021271360.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 279 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of May 28, 2021, in each case subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
May 28, 2022 Filed Jun 1, 2022 21:50 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionCommon Stock	279	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000085 · wf-form4_165412021271360.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 27, 2022 Filed Jun 1, 2022 23:35 UTC	Lyft, Inc. LYFT · Entity 2493	SaleClass A Common Stock	553	$17.94	$9,919.27	Disclosure SEC source: 0001209191-22-033311 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,824 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.73 to $18.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document
April 05, 2022 Filed Apr 7, 2022 22:04 UTC	Hewlett Packard Enterprise Co HPE · Entity 2984	Exercise / conversionRestricted Stock Units · Derivative	14,479	Not disclosed	Not disclosed	Disclosure SEC source: 0001062993-22-009956 · form4.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,479 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: As previously reported, on 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 117.5568 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 07/07/21, 115.3990 dividend equivalent rights at $14.71 per RSU credited to the reporting person's account on 10/06/21, 99.0963 dividend equivalent rights at $17.13 per RSU credited to the reporting person's account on 01/07/22. F3 · shares: The number of shares in column 5 includes 333 vested RSU dividend equivalent rights and a de minimus adjustment of 0.9479 due to fractional rounding of the dividend equivalent rights at $16.26 per RSU credited to the reporting person's account on 04/05/22. F2 · price: As previously reported, on 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 117.5568 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 07/07/21, 115.3990 dividend equivalent rights at $14.71 per RSU credited to the reporting person's account on 10/06/21, 99.0963 dividend equivalent rights at $17.13 per RSU credited to the reporting person's account on 01/07/22. F2 · derivative.exercise_date: As previously reported, on 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 117.5568 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 07/07/21, 115.3990 dividend equivalent rights at $14.71 per RSU credited to the reporting person's account on 10/06/21, 99.0963 dividend equivalent rights at $17.13 per RSU credited to the reporting person's account on 01/07/22. F2 · derivative.expiration_date: As previously reported, on 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 117.5568 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 07/07/21, 115.3990 dividend equivalent rights at $14.71 per RSU credited to the reporting person's account on 10/06/21, 99.0963 dividend equivalent rights at $17.13 per RSU credited to the reporting person's account on 01/07/22. Read SEC document
April 05, 2022 Filed Apr 7, 2022 22:04 UTC	Hewlett Packard Enterprise Co HPE · Entity 2984	Exercise / conversionCommon Stock	14,479	$0.00	$0.00	Disclosure SEC source: 0001062993-22-009956 · form4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 28, 2022 Filed Mar 1, 2022 22:26 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionRestricted Stock Units · Derivative	279	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000024 · wf-form4_164617354503122.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279 Underlying: Common Stock · 279 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of May 28, 2021, in each case subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
February 28, 2022 Filed Mar 1, 2022 22:26 UTC	DOCUSIGN, INC. DOCU · Entity 2242	Exercise / conversionCommon Stock	279	$0.00	$0.00	Disclosure SEC source: 0001261333-22-000024 · wf-form4_164617354503122.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 28, 2022 Filed Mar 2, 2022 22:07 UTC	Lyft, Inc. LYFT · Entity 2493	SaleClass A Common Stock	125	$39.23	$4,904.30	Disclosure SEC source: 0001209191-22-014876 · doc4.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,377 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $39.00 to $39.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document
February 28, 2022 Filed Mar 2, 2022 22:07 UTC	Lyft, Inc. LYFT · Entity 2493	SaleClass A Common Stock	429	$38.54	$16,533.15	Disclosure SEC source: 0001209191-22-014876 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,502 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $38.00 to $38.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document
December 21, 2021 Filed Dec 22, 2021 20:16 UTC	COSTCO WHOLESALE CORP /NEW COST · Entity 2803	PurchaseCommon Stock	925	$540.13	$499,619.51	Disclosure SEC source: 0001209191-21-070914 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,445 F1 · price: The price shown is a weighted average price for shares purchased in multiple transactions; the purchase prices ranged from $539.98 to $540.30 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document
November 29, 2021 Filed Dec 2, 2021 01:32 UTC	Lyft, Inc. LYFT · Entity 2493	SaleClass A Common Stock	27	$43.17	$1,165.72	Disclosure SEC source: 0001209191-21-067382 · doc4.xml · nonDerivative · entry 3 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,931 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $43.00 to $43.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document
November 29, 2021 Filed Dec 2, 2021 01:32 UTC	Lyft, Inc. LYFT · Entity 2493	SaleClass A Common Stock	70	$42.31	$2,961.37	Disclosure SEC source: 0001209191-21-067382 · doc4.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,958 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $41.92 to $42.90. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.